FDA Approves ANDA078324 for Estradiol and Norethindrone Acetate
The FDA has granted approval for ANDA078324, a generic formulation of estradiol and norethindrone acetate.
Company
Pharmaceutical intelligence for Breckenridge Pharma with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.